FiercePharma ✓

@FiercePharma · West End, District of Columbia · joined 21 Dec 2008

Pharma’s go-to destination for news & trends shaping approved drugs. Delivering news, revealing insights straight to your inbox.

100 766Followers

469Following

35 502Posts total

59.5KViews on collected posts

Последние посты

FiercePharma ✓@FiercePharma8 Sep

In further validation of the DLL3 target pioneered by Amgen’s Imdelltra, the T-cell engager has delivered an overall survival win in first-line small cell lung cancer. https://t.co/YOlNxdun0P 2.7K views · 16 likes · 4 reposts · 3 replies Open on X →

FiercePharma ✓@FiercePharma4 Sep

Daiichi Sankyo subsidiary American Regent is launching a recall of three lots of generic epinephrine as it becomes one of the latest manufacturers to face headaches over particulate contamination in its drug products. https://t.co/N4CG2kzoJw 3.4K views · 7 likes · 0 reposts · 3 replies Open on X →

FiercePharma ✓@FiercePharma4 Sep

Martina Flammer helped advance brensocatib from development through FDA approval as the first DPP1 inhibitor for bronchiectasis. She is a 2026 Fierce 50 Breakthrough honoree. 🔗https://t.co/VGKKBwdkME @Insmed #Fierce50 https://t.co/bOR9rhyYRR

2.7K views · 5 likes · 0 reposts · 1 replies Open on X →

FiercePharma ✓@FiercePharma3 Sep

@FiercePharma Strong early uptake shows the impact access and affordability can have on GLP-1 adoption. It will be interesting to see how this shapes patient demand and the broader obesity treatment market. 68 views · 0 likes · 0 reposts · 0 replies Open on X →

FiercePharma ✓@FiercePharma2 Sep

As part of the MFN drug pricing deal the Trump administration signed with obesity giants Eli Lilly and Novo Nordisk, Medicare recently launched a “bridge” model, offering weight loss drugs to eligible seniors at $50 per month. Now, we know the initial uptake from the program. 8.2K views · 9 likes · 3 reposts · 1 replies Open on X →

FiercePharma ✓@FiercePharma1 Sep

Congrats to Eric Topol, one of this year’s Fierce 50 Leadership honorees, recognized for decades of work advancing digital medicine and for helping define both the promise and limits of AI in healthcare. 5.5K views · 19 likes · 2 reposts · 2 replies Open on X →

FiercePharma ✓@FiercePharma1 Sep

Thanks for the leadership recognition @FiercePharma @FierceBiotech https://t.co/FnPJDQCZhd 29.5K views · 118 likes · 8 reposts · 9 replies Open on X →

FiercePharma ✓@FiercePharma28 Aug

The Oral GLP-1 Tracker: Lilly's Foundayo scripts cross 40K https://t.co/sHrXXXhEpk 3.7K views · 10 likes · 2 reposts · 1 replies Open on X →

FiercePharma ✓@FiercePharma27 Aug

An inexperienced RevMed is now responsible for launching the most hotly anticipated cancer drug in years. https://t.co/vfyPNDK7uH 3.7K views · 11 likes · 3 reposts · 1 replies Open on X →

На фоне аккаунтов своего размера

9 постов за последние 90 дней рядом с диапазоном 100K–1M подписчиков. показывается широко, но откликается мало кто.

Медианные просмотры3 686этот аккаунт5 983медиана для 100K–1M

Охват, %3.66%этот аккаунт1.49%медиана для 100K–1M

Вовлечённость, %0.35%этот аккаунт0.93%медиана для 100K–1M

Показатель	Этот аккаунт	Медиана для 100K–1M	Отношение
Медианные просмотры на пост	3 686	5 983	0.62×
Охват (просмотры ÷ подписчики)	3.66%	1.49%	2.46×
Вовлечённость	0.35%	0.93%	0.38×

Другие в этом диапазоне → Сравнить с другим аккаунтом → Как считаются эти ориентиры →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

3.7K27 Aug

3.7K28 Aug

29.5K1 Sep

5.5K

8.2K2 Sep

683 Sep

2.7K4 Sep

3.4K

2.7K8 Sep

Last 9 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.41%27 Aug

0.35%28 Aug

0.46%1 Sep

0.42%

0.18%2 Sep

0.00%3 Sep

0.22%4 Sep

0.32%

0.90%8 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 100K–1M accounts is 0.93%.

What the audience does

Likes74.7%195 in total

Reposts8.4%22 in total

Replies8.0%21 in total

Quotes2.3%6 in total

Bookmarks6.5%17 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.